Current Neuro-Oncology
Volume
24 Number 6
31 March 2022
Home > Publications > Current Neuro-Oncology > Volume 24, Year 2022 > Number 6, 31 March
*
Junior
AG, M P Abreu N, B Leal MV, L A de Aquino H, C Rodrigues JP, B
Malveira C, P Silva Y, P A Coimbra P.
A
Case Report of a Rare Pediatric Brain
Tumor:
Congenital Glioblastoma.
Cureus.
2022 Mar 16;14(3):e23229∟.
doi: 10.7759/cureus.23229∟.
PMID: 35449680∟.
Case report. ˍ
Yuile
AK, Kastelan M, Lee AP, Back M, Drummond J, Wheeler HR.
The
use of Sonidegib
in the adjuvant and advanced phases of Sonic Hedge Hog Mutant
Medulloblastomas.
Oxf
Med Case Reports. 2022 Mar 16;2022(3):omac019∟.
doi: 10.1093/omcr/omac019∟.
PMID: 35316996∟.
Case report. ˍ
Tirrò
E, Massimino M, Broggi G, Romano C, Minasi S, Gianno F, Antonelli
M, Motta G, Certo F, Altieri R, Manzella L, Caltabiano R,
Barbagallo GMV, Buttarelli FR, Magro G, Giangaspero F, Vigneri
P.
A
Custom DNA-Based NGS Panel
for
the Molecular Characterization of Patients With Diffuse Gliomas:
Diagnostic and
Therapeutic Applications.
Front
Oncol. 2022 Mar 17;12:861078∟.
doi: 10.3389/fonc.2022.861078∟.
PMID: 35372034∟.
Laboratory investigation. ˍ
Liu
Y, Chen L.
Comparison
of Clinical Effects of Temozolomide Single Agent
and
Combined Doxorubicin in the Treatment of Glioma.
J
Healthc Eng. 2022 Mar 19;2022:7995385∟.
doi: 10.1155/2022/7995385∟.
PMID: 35345663∟.
Observational study. ˍ
Climans
SA, Grunfeld E, Mason WP, Chan KKW.
Effectiveness
and Safety of
Pneumocystis
Pneumonia Prophylaxis for Patients Receiving Temozolomide
Chemoradiotherapy.
Neuro
Oncol. 2022 Mar 21;24(10):1738-1748∟.
doi: 10.1093/neuonc/noac072∟.
PMID: 35312784∟.
Observational study˰ ˍ
Le
Rhun E, Oppong FB, Vanlancker M, Stupp R, Nabors B, Chinot O, Wick
W, Preusser M, Gorlia T, Weller M.
Prognostic
significance of therapy-induced
myelosuppression
in newly diagnosed glioblastoma.
Neuro
Oncol. 2022 Mar 21;24(9):1533-1545∟.
doi: 10.1093/neuonc/noac070∟.
PMID: 35312789∟.
Observational study˰
ˍ
Shahsavari N, Ahmad M, Sekar V,
Meola A, Hancock SL, Chang SD, Chiang VL.
Synchronous
glioblastoma and brain metastases: illustrative case.
J
Neurosurg Case Lessons. 2022 Mar 21;3(12):CASE21714∟.
doi: 10.3171/CASE21714∟.
PMID: 36273867∟.
Case report. ˍ
*
Blobner
J, Tonn JC.
Resection
of glioma - Feeding the beast?
Neuro
Oncol. 2022 Mar 22;24(7):1088-1089∟.
doi: 10.1093/neuonc/noac078∟.
PMID: 35323960∟.
Editorial˰ ˍ
Refers
to: Knudsen
AM, et al., Surgical resection of glioblastomas induces
pleiotrophin-mediated
self-renewal
of glioblastoma stem cells in recurrent tumors.
Neuro Oncol.
2021 Dec 29;24(7):1074-1087∟.
doi: 10.1093/neuonc/noab302∟.
PMID: 34964899∟.
Laboratory investigation. ˍ
Gabriel
NN, Balaji K, Jayachandran K, Inkman M, Zhang J, Dahiya S,
Goldstein M.
Loss
of H3K27 trimethylation promotes radiotherapy resistance in
medulloblastoma
and induces an actionable vulnerability to BET inhibition.
Cancer
Res. 2022 Mar 22;82(10):2019-2030∟.
doi: 10.1158/0008-5472.CAN-21-0871∟.
PMID: 35315927∟.
Laboratory investigation. ˍ
Bady
P, Marosi C, Weller M, Grønberg BH, Schultz H, Taphoorn
MJB, Gijtenbeek JMM, van den Bent MJ, von Deimling A, Stupp R,
Malmström A, Hegi ME.
DNA
methylation-based
age acceleration observed in IDH wild-type glioblastoma is
associated
with better outcome-including in elderly patients.
Acta
Neuropathol Commun. 2022 Mar 24;10(1):39∟.
doi: 10.1186/s40478-022-01344-5∟.
PMID: 35331339∟.
Observational study. ˍ
Vennarini
S, Del Baldo G, Lorentini S, Pertile R, Fabozzi F, Merli P, Megaro
G, Scartoni D, Carai A, Tornesello A, Colafati GS, Cacchione A,
Mastronuzzi A.
Acute
Hematological Toxicity during Cranio-Spinal Proton Therapy in
Pediatric Brain
Embryonal Tumors.
Cancers
(Basel). 2022 Mar 24;14(7):1653∟.
doi: 10.3390/cancers14071653∟.
PMID: 35406425∟.
Observational study. ˍ
Yang
S, Xie C, Guo T, Li H, Li N, Zhou S, Wang X, Xie C.
Simvastatin
Inhibits Tumor Growth and Migration by Mediating
Caspase-1-dependent Pyroptosis in Glioblastoma Multiforme.
World
Neurosurg. 2022 Mar 25;165:e12-e21∟.
doi: 10.1016/j.wneu.2022.03.089∟.
PMID: 35342027∟.
Laboratory investigation˰ ˍ
Lassman
AB, Sepúlveda-Sánchez JM, Cloughesy T, Gil-Gil MJ,
Puduvalli VK, Raizer J, De Vos FYF, Wen PY, Butowski N, Clement
PMJ, Groves MD, Belda-Iniesta C, Giglio P, Soifer HS, Rowsey S, Xu
C, Avogadri F, Wei G, Moran S, Roth P.
Infigratinib
in Patients with Recurrent Gliomas and FGFR Alterations: A
Multicenter
Phase II Study.
Clin
Cancer Res. 2022 Mar 28;28(11):2270-2277∟.
doi: 10.1158/1078-0432.CCR-21-2664∟.
PMID: 35344029∟.
Interventional study.
ˍ
*
Şenkesen
Ö, Tezcanlı E, Abacıoğlu MU, Özen Z, Çöne
D, Küçücük H, Göksel EO, Arifoğlu
A, Şengöz M.
Limited
field adaptive radiotherapy for glioblastoma: changes in target
volume and organ at risk doses.
Radiat
Oncol J. 2022 Mar 28;40(1):9-19∟.
doi: 10.3857/roj.2021.00542∟.
PMID: 35368196∟.
Observational study.
ˍ
Schüz
J, Pirie K, Reeves GK, Floud S, Beral V; Million Women Study
Collaborators.
Cellular
Telephone Use and the Risk of Brain Tumors: Update of
the
UK Million Women Study.
J
Natl Cancer Inst. 2022 Mar 29;114(5):704-711∟.
doi: 10.1093/jnci/djac042∟.
PMID: 35350069∟.
Observational study. ˍ
Zeiner
PS, Filipski K, Filmann N, Forster MT, Voss M, Fokas E, Herrlinger
U, Harter PN, Steinbach JP, Ronellenfitsch MW.
Sex-Dependent
Analysis of Temozolomide-Induced Myelosuppression and Effects on
Survival in a Large Real-life Cohort of Glioma
Patients.
Neurology.
2022 Mar 29;98(20):e2073-e2083∟.
doi: 10.1212/WNL.0000000000200254∟.
PMID: 35351796∟.
Observational study˰ ˍ
Hazra
S, Kundu S, Dutta B, Deb AR.
Primary
intramedullary spinal gliosarcoma:
An
unusual presentation.
J
Cancer Res Ther. 2022 Mar 30;18(1):270-272∟.
doi: 10.4103/jcrt.JCRT_182_20?. PMID: 35381798∟.
Case report. ˍ